No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
XRTX XORTX Therapeutics
- 1.9500
- +0.3400+21.12%
Close Jul 12 16:00 ET
- 1.8201
- -0.1299-6.66%
Post 19:56 ET
5.66MMarket Cap-1413P/E (TTM)
2.8000High1.5200Low3.04MVolume1.6600Open1.6100Pre Close6.96MTurnover114.93%Turnover RatioLossP/E (Static)2.90MShares7.524052wk High2.27P/B5.15MFloat Cap1.520052wk Low--Dividend TTM2.64MShs Float55.0800Historical High--Div YieldTTM79.50%Amplitude1.5200Historical Low2.2930Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
XORTX Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Stocks in Play: XORTX Therapeutics Inc.
XORTX Therapeutics Adjusts Warrant Terms
XORTX Therapeutics Brief: Says Repriced Balance of Warrants Issued in Connection With October 2021 US IPO
07:01 AM EDT, 05/17/2024 (MT Newswires) -- XORTX Therapeutics Brief: Says Repriced Balance of Warrants Issued in Connection with October 2021 US IPO
XORTX Reprices Balance of Warrants Issued in Connection With October 2021 US IPO
CALGARY, Alberta, May 17, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late stage clinical pharmaceutical company focused on developing
Xortx Therapeutics Q1 Financial Snapshot
Comments
1
2
$XORTX Therapeutics(XRTX.US$ Watching this. 👀
1
3
$XORTX Therapeutics(XRTX.US$ Wow… CB out of nowhere
Dr. Perrone's addition to XORTX's Clinical Advisory Board is viewed positively due to his extensive medical and professional experience, especially in ADPKD and kidney disease. His clinical research, trials, and regulatory agency work are anticipated to significantly contribute to XORTX's advanced clinical program and the XRX-OXY-201 registration trial.
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Salmon Klein : ypu did well...I got in for a quick 5% gain and didn't take my order (doing something weird in black pools look like) and in the next candle hit my SL...2 days in a row losing wtf!!
FattyChickOP Salmon Klein: Go for a more quality stock, which >100mil mcap.